Condition

CD - Crohn's Disease clinical trials and research

As of November 12, 2026, Find a Trial lists 3 CD - Crohn's Disease clinical trials that are recruiting, in China. By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest CD - Crohn's Disease clinical trials

StudyPhaseWhereStatusRegistered
BDHK-2009 safety test in healthy adults Phase 1 Hangzhou, Zhejiang Recruiting Jun 8, 2026
Guselkumab vs Ustekinumab for stricturing Crohn's disease — Hangzhou, Zhejiang Recruiting Mar 2, 2026
Dexamethasone before infliximab for moderate-to-severe Crohn's disease and ulcerative colitis — Hangzhou, Zhejiang Recruiting Feb 3, 2026

All recruiting trials (3)

Related topics

IBD (Inflammatory Bowel Disease)BowelInflammatory Bowel Disease (IBD)StrictureUC - Ulcerative ColitisUlcerative Colitis AcuteUlcerative Colitis (Disorder)Ulcerative Colitis (UC)GuselkumabInfliximabUstekinumab

Quick answers

How many CD - Crohn's Disease clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.